Abstract

TERIPARATIDE IN POST-MENOPAUSAL OSTEOPOROSIS - A NEW REVOLUTION FOR OSTEOPOROSIS

Indrani Devi Sarma, Dhriti Kr. Brahma* and Priyotosh Banerjee

.

Abstract

Osteoporosis is a clinical condition resulting in bone resorption and weakening of bones leading to fractures and brittle bones. Even the slightest cough, mild stress or fall can lead to fracturing of bones. Various factors play a vital role in the development of osteoporosis and it is slowly emerging as a common problem in post menopausal women. There are no symptoms in the early stages of bone loss. But once the bones have been weakened by osteoporosis, signs and symptoms like back pain, loss of height or a stooped posture starts appearing. The current treatment protocol includes medications that slow down the bone resorption. Teriparatide is an anabolic drug that promotes bone formation and has been approved by the Food And Drug Administration and Central Drugs Standard Control Organisation for the treatment of osteoporosis in post menopausal women who are at high risk of fracture.

Keywords: Teriparatide, Osteoporosis, post menopausal, fracture, anabolic agents.